118 related articles for article (PubMed ID: 27773853)
1. Advancing pharmaceutical quality: An overview of science and research in the U.S. FDA's Office of Pharmaceutical Quality.
Fisher AC; Lee SL; Harris DP; Buhse L; Kozlowski S; Yu L; Kopcha M; Woodcock J
Int J Pharm; 2016 Dec; 515(1-2):390-402. PubMed ID: 27773853
[TBL] [Abstract][Full Text] [Related]
2. A network of regulatory innovations to improve FDA quality assessments of human drug applications.
Tran R; Fraser G; Fisher AC; Lee SL; Boam A; Tsinontides S; Maguire J; Yu LX; Rosencrance S; Kozlowski S; Henry D
Int J Pharm X; 2024 Jun; 7():100239. PubMed ID: 38545329
[TBL] [Abstract][Full Text] [Related]
3. Translating New Science Into the Drug Review Process: The US FDA's Division of Applied Regulatory Science.
Rouse R; Kruhlak N; Weaver J; Burkhart K; Patel V; Strauss DG
Ther Innov Regul Sci; 2018 Mar; 52(2):244-255. PubMed ID: 29568713
[TBL] [Abstract][Full Text] [Related]
4. Advancing Regulatory Science With Computational Modeling for Medical Devices at the FDA's Office of Science and Engineering Laboratories.
Morrison TM; Pathmanathan P; Adwan M; Margerrison E
Front Med (Lausanne); 2018; 5():241. PubMed ID: 30356350
[TBL] [Abstract][Full Text] [Related]
5. Evolution of Cross-Sectional Survey Protocol Quality Over Time: A Case Series of Index U.S. REMS Knowledge Survey Protocols (2007-2020).
Toyserkani GA; Ewusie SB; Turk P; Quick J; Morrato EH
Drug Saf; 2023 Nov; 46(11):1073-1087. PubMed ID: 37697204
[TBL] [Abstract][Full Text] [Related]
6. Regenerative Medicine Therapies for Rare Diseases.
Lapteva L; Vatsan R; Purohit-Sheth T
Transl Sci Rare Dis; 2018 Dec; 3(3-4):121-132. PubMed ID: 30613470
[TBL] [Abstract][Full Text] [Related]
7. Drug and medical device product failures and the stability of the pharmaceutical supply chain.
Livingston AN; Mattingly TJ
J Am Pharm Assoc (2003); 2021; 61(1):e119-e122. PubMed ID: 32753251
[TBL] [Abstract][Full Text] [Related]
8. FDA Warning Letters: A Retrospective Analysis of Letters Issued to Pharmaceutical Companies from 2010-2020.
Rathore AS; Li Y; Chhabra H; Lohiya A
J Pharm Innov; 2022 Aug; ():1-10. PubMed ID: 35992018
[TBL] [Abstract][Full Text] [Related]
9. FDA Global Drug Inspections: Surveillance Of Manufacturing Establishments Remains Well Below Pre-COVID-19 Levels.
Cuddy E; Lu YP; Ridley DB
Health Aff (Millwood); 2023 Dec; 42(12):1758-1766. PubMed ID: 38048499
[TBL] [Abstract][Full Text] [Related]
10. Spectrometric Assessment of Generic and Brand Drug Quality for a Sentinel Screening Network.
Isaacs JT; Almeter PJ; Henderson BS; Hunter AN; Platt TL; Lodder RA
Appl Spectrosc; 2023 Aug; 77(8):915-927. PubMed ID: 37475201
[TBL] [Abstract][Full Text] [Related]
11. Regulatory scientists' work has important ramifications for public health and should be open to public scrutiny.
Mulinari S; Davis C
Health Res Policy Syst; 2018 Nov; 16(1):98. PubMed ID: 30428900
[TBL] [Abstract][Full Text] [Related]
12. Scientific Prospects for Cannabis-Microbiome Research to Ensure Quality and Safety of Products.
Vujanovic V; Korber DR; Vujanovic S; Vujanovic J; Jabaji S
Microorganisms; 2020 Feb; 8(2):. PubMed ID: 32093340
[No Abstract] [Full Text] [Related]
13. Structured content and data management-enhancing acceleration in drug development through efficiency in data exchange.
Beierle J; Algorri M; Cortés M; Cauchon NS; Lennard A; Kirwan JP; Oghamian S; Abernathy MJ
AAPS Open; 2023; 9(1):11. PubMed ID: 37193559
[TBL] [Abstract][Full Text] [Related]
14. Frustration Over Generic Drug Shortages and Prices Prompts Federal and Private Actions: Health Systems Take Matters Into Their Own Hands.
Barlas S
P T; 2018 Apr; 43(4):211-213. PubMed ID: 29622941
[TBL] [Abstract][Full Text] [Related]
15. Advancing regulatory science through real-world data and real-world evidence.
Cure P; Fessel JP; Hartshorn CM; Steele SJ
J Clin Transl Sci; 2024; 8(1):e87. PubMed ID: 38784107
[No Abstract] [Full Text] [Related]
16. Benefit-risk assessment in pharmaceutical research and development.
Haddad J
Pharm Stat; 2014 Jun; ():. PubMed ID: 24931614
[No Abstract] [Full Text] [Related]
17. Biosimilars: The US Regulatory Framework.
Christl LA; Woodcock J; Kozlowski S
Annu Rev Med; 2017 Jan; 68():243-254. PubMed ID: 27813877
[TBL] [Abstract][Full Text] [Related]
18. Mathematical modeling and digital design of an intensified filtration-washing-drying unit for pharmaceutical continuous manufacturing.
Destro F; Hur I; Wang V; Abdi M; Feng X; Wood E; Coleman S; Firth P; Barton A; Barolo M; Nagy ZK
Chem Eng Sci; 2021; 244():. PubMed ID: 38229929
[TBL] [Abstract][Full Text] [Related]
19. A benchmark simulator for quality-by-design and quality-by-control studies in continuous pharmaceutical manufacturing - Intensified filtration-drying of crystallization slurries.
Destro F; Nagy ZK; Barolo M
Comput Chem Eng; 2022 Jul; 163():. PubMed ID: 38178942
[TBL] [Abstract][Full Text] [Related]
20. Lubricant Sensitivity of Direct Compression Grades of Lactose in Continuous and Batch Tableting Process.
Hebbink GA; Janssen PHM; Kok JH; Menarini L; Giatti F; Funaro C; Consoli SF; Dickhoff BHJ
Pharmaceutics; 2023 Nov; 15(11):. PubMed ID: 38004554
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
